Walleye Trading LLC Ultragenyx Pharmaceutical Inc. Put Options Transaction History

Walleye Trading LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	SELL	$31.73 - $49.19 $133,266 - $206,598	-4,200 Reduced 52.5%	3,800 $181,000
Q3 2023 Nov 14, 2023	BUY	$34.92 - $46.66 $174,600 - $233,299	5,000 Added 166.67%	8,000 $285,000
Q2 2023 Aug 14, 2023	BUY	$37.35 - $52.15 $112,050 - $156,450	3,000 New	3,000 $138,000
Q4 2022 Feb 14, 2023	BUY	$33.72 - $46.33 $40,464 - $55,596	1,200 New	1,200 $55,000
Q2 2022 Aug 08, 2022	SELL	$45.8 - $85.4 $1.1 Million - $2.06 Million	-24,100 Reduced 54.65%	20,000 $1.19 Million
Q1 2022 May 16, 2022	BUY	$62.2 - $84.4 $1.35 Million - $1.83 Million	21,700 Added 96.88%	44,100 $3.2 Million
Q4 2021 Feb 14, 2022	BUY	$73.71 - $87.86 $1.65 Million - $1.97 Million	22,400 New	22,400 $1.88 Million
Q2 2021 Aug 16, 2021	SELL	$92.19 - $115.71 $230,475 - $289,275	-2,500 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$106.9 - $167.73 $181,730 - $285,141	1,700 Added 212.5%	2,500 $285,000
Q4 2020 Feb 16, 2021	BUY	$84.4 - $177.39 $67,520 - $141,912	800 New	800 $111,000

325

85.6M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.11B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.